Acquired immunodeficiency syndrome (AIDS) is one of the most widespread, catastrophic, and incurable diseases among humans in the world. According to a report published by the World Health Organization (WHO) in 2013, deaths caused by HIV ranked sixth in the total number of deaths in the world. Human immunodeficiency virus (HIV) presents itself as a complex mixture of symptoms, all related to severe immune compromise, while AIDS is an advanced stage of HIV infection.
This report aims to provide a comprehensive presentation of the global market for Acquired Immunodeficiency Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acquired Immunodeficiency Syndrome. This report contains market size and forecasts of Acquired Immunodeficiency Syndrome in global, including the following market information:
Global Acquired Immunodeficiency Syndrome Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Acquired Immunodeficiency Syndrome market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acquired Immunodeficiency Syndrome include Takeda, AstraZeneca Eli Lilly and Company, Merck KGaA, Sanofi, Pfizer, Amgen, Biogen, Novartis and Actelion, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acquired Immunodeficiency Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acquired Immunodeficiency Syndrome Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Acquired Immunodeficiency Syndrome Market Segment Percentages, by Type, 2022 (%)
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Global Acquired Immunodeficiency Syndrome Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Acquired Immunodeficiency Syndrome Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Others
Global Acquired Immunodeficiency Syndrome Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Acquired Immunodeficiency Syndrome Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acquired Immunodeficiency Syndrome revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Acquired Immunodeficiency Syndrome revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
AstraZeneca Eli Lilly and Company
Merck KGaA
Sanofi
Pfizer
Amgen
Biogen
Novartis
Actelion
Daiichi Sankyo Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acquired Immunodeficiency Syndrome, market overview.
Chapter 2: Global Acquired Immunodeficiency Syndrome market size in revenue.
Chapter 3: Detailed analysis of Acquired Immunodeficiency Syndrome company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acquired Immunodeficiency Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acquired Immunodeficiency Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acquired Immunodeficiency Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acquired Immunodeficiency Syndrome Overall Market Size
2.1 Global Acquired Immunodeficiency Syndrome Market Size: 2022 VS 2030
2.2 Global Acquired Immunodeficiency Syndrome Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acquired Immunodeficiency Syndrome Players in Global Market
3.2 Top Global Acquired Immunodeficiency Syndrome Companies Ranked by Revenue
3.3 Global Acquired Immunodeficiency Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Acquired Immunodeficiency Syndrome Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acquired Immunodeficiency Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acquired Immunodeficiency Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Acquired Immunodeficiency Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Acquired Immunodeficiency Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acquired Immunodeficiency Syndrome Market Size Markets, 2022 & 2030
4.1.2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
4.1.3 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
4.2 By Type - Global Acquired Immunodeficiency Syndrome Revenue & Forecasts
4.2.1 By Type - Global Acquired Immunodeficiency Syndrome Revenue, 2018-2023
4.2.2 By Type - Global Acquired Immunodeficiency Syndrome Revenue, 2024-2030
4.2.3 By Type - Global Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acquired Immunodeficiency Syndrome Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Acquired Immunodeficiency Syndrome Revenue & Forecasts
5.2.1 By Application - Global Acquired Immunodeficiency Syndrome Revenue, 2018-2023
5.2.2 By Application - Global Acquired Immunodeficiency Syndrome Revenue, 2024-2030
5.2.3 By Application - Global Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Acquired Immunodeficiency Syndrome Market Size, 2022 & 2030
6.2 By Region - Global Acquired Immunodeficiency Syndrome Revenue & Forecasts
6.2.1 By Region - Global Acquired Immunodeficiency Syndrome Revenue, 2018-2023
6.2.2 By Region - Global Acquired Immunodeficiency Syndrome Revenue, 2024-2030
6.2.3 By Region - Global Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Acquired Immunodeficiency Syndrome Revenue, 2018-2030
6.3.2 US Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.3.3 Canada Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.3.4 Mexico Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Acquired Immunodeficiency Syndrome Revenue, 2018-2030
6.4.2 Germany Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.4.3 France Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.4.4 U.K. Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.4.5 Italy Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.4.6 Russia Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.4.7 Nordic Countries Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.4.8 Benelux Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Acquired Immunodeficiency Syndrome Revenue, 2018-2030
6.5.2 China Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.5.3 Japan Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.5.4 South Korea Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.5.5 Southeast Asia Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.5.6 India Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Acquired Immunodeficiency Syndrome Revenue, 2018-2030
6.6.2 Brazil Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.6.3 Argentina Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acquired Immunodeficiency Syndrome Revenue, 2018-2030
6.7.2 Turkey Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.7.3 Israel Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.7.4 Saudi Arabia Acquired Immunodeficiency Syndrome Market Size, 2018-2030
6.7.5 UAE Acquired Immunodeficiency Syndrome Market Size, 2018-2030
7 Acquired Immunodeficiency Syndrome Companies Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Acquired Immunodeficiency Syndrome Major Product Offerings
7.1.4 Takeda Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 AstraZeneca Eli Lilly and Company
7.2.1 AstraZeneca Eli Lilly and Company Company Summary
7.2.2 AstraZeneca Eli Lilly and Company Business Overview
7.2.3 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Major Product Offerings
7.2.4 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Eli Lilly and Company Key News & Latest Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Company Summary
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Acquired Immunodeficiency Syndrome Major Product Offerings
7.3.4 Merck KGaA Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.3.5 Merck KGaA Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Acquired Immunodeficiency Syndrome Major Product Offerings
7.4.4 Sanofi Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Acquired Immunodeficiency Syndrome Major Product Offerings
7.5.4 Pfizer Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Acquired Immunodeficiency Syndrome Major Product Offerings
7.6.4 Amgen Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Biogen
7.7.1 Biogen Company Summary
7.7.2 Biogen Business Overview
7.7.3 Biogen Acquired Immunodeficiency Syndrome Major Product Offerings
7.7.4 Biogen Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.7.5 Biogen Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Acquired Immunodeficiency Syndrome Major Product Offerings
7.8.4 Novartis Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Actelion
7.9.1 Actelion Company Summary
7.9.2 Actelion Business Overview
7.9.3 Actelion Acquired Immunodeficiency Syndrome Major Product Offerings
7.9.4 Actelion Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.9.5 Actelion Key News & Latest Developments
7.10 Daiichi Sankyo Company
7.10.1 Daiichi Sankyo Company Company Summary
7.10.2 Daiichi Sankyo Company Business Overview
7.10.3 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Major Product Offerings
7.10.4 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue in Global Market (2018-2023)
7.10.5 Daiichi Sankyo Company Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Acquired Immunodeficiency Syndrome Market Opportunities & Trends in Global Market
Table 2. Acquired Immunodeficiency Syndrome Market Drivers in Global Market
Table 3. Acquired Immunodeficiency Syndrome Market Restraints in Global Market
Table 4. Key Players of Acquired Immunodeficiency Syndrome in Global Market
Table 5. Top Acquired Immunodeficiency Syndrome Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acquired Immunodeficiency Syndrome Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acquired Immunodeficiency Syndrome Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acquired Immunodeficiency Syndrome Product Type
Table 9. List of Global Tier 1 Acquired Immunodeficiency Syndrome Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acquired Immunodeficiency Syndrome Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Acquired Immunodeficiency Syndrome Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acquired Immunodeficiency Syndrome Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Acquired Immunodeficiency Syndrome Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acquired Immunodeficiency Syndrome Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Acquired Immunodeficiency Syndrome Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acquired Immunodeficiency Syndrome Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2024-2030
Table 30. Takeda Company Summary
Table 31. Takeda Acquired Immunodeficiency Syndrome Product Offerings
Table 32. Takeda Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 33. Takeda Key News & Latest Developments
Table 34. AstraZeneca Eli Lilly and Company Company Summary
Table 35. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Offerings
Table 36. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Eli Lilly and Company Key News & Latest Developments
Table 38. Merck KGaA Company Summary
Table 39. Merck KGaA Acquired Immunodeficiency Syndrome Product Offerings
Table 40. Merck KGaA Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 41. Merck KGaA Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Acquired Immunodeficiency Syndrome Product Offerings
Table 44. Sanofi Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Acquired Immunodeficiency Syndrome Product Offerings
Table 48. Pfizer Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Acquired Immunodeficiency Syndrome Product Offerings
Table 52. Amgen Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Biogen Company Summary
Table 55. Biogen Acquired Immunodeficiency Syndrome Product Offerings
Table 56. Biogen Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 57. Biogen Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Acquired Immunodeficiency Syndrome Product Offerings
Table 60. Novartis Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Actelion Company Summary
Table 63. Actelion Acquired Immunodeficiency Syndrome Product Offerings
Table 64. Actelion Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 65. Actelion Key News & Latest Developments
Table 66. Daiichi Sankyo Company Company Summary
Table 67. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Offerings
Table 68. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue (US$, Mn) & (2018-2023)
Table 69. Daiichi Sankyo Company Key News & Latest Developments
List of Figures
Figure 1. Acquired Immunodeficiency Syndrome Segment by Type in 2022
Figure 2. Acquired Immunodeficiency Syndrome Segment by Application in 2022
Figure 3. Global Acquired Immunodeficiency Syndrome Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acquired Immunodeficiency Syndrome Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Acquired Immunodeficiency Syndrome Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acquired Immunodeficiency Syndrome Revenue in 2022
Figure 8. By Type - Global Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 9. By Application - Global Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 10. By Type - Global Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 12. By Application - Global Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 14. By Region - Global Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 15. By Country - North America Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 16. US Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 20. Germany Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 21. France Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 28. China Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 32. India Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 34. Brazil Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Acquired Immunodeficiency Syndrome Revenue Market Share, 2018-2030
Figure 37. Turkey Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Acquired Immunodeficiency Syndrome Revenue, (US$, Mn), 2018-2030
Figure 41. Takeda Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck KGaA Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biogen Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Actelion Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
